Gsa Capital Partners LLP Elanco Animal Health Inc Transaction History
Gsa Capital Partners LLP
- $1.35 Billion
- Q4 2024
A detailed history of Gsa Capital Partners LLP transactions in Elanco Animal Health Inc stock. As of the latest transaction made, Gsa Capital Partners LLP holds 54,492 shares of ELAN stock, worth $606,495. This represents 0.05% of its overall portfolio holdings.
Number of Shares
54,492
Previous 30,992
75.83%
Holding current value
$606,495
Previous $455,000
45.05%
% of portfolio
0.05%
Previous 0.03%
Shares
16 transactions
Others Institutions Holding ELAN
# of Institutions
438Shares Held
448MCall Options Held
1.16MPut Options Held
1.12M-
Dodge & Cox San Francisco, CA83.2MShares$926 Million0.63% of portfolio
-
Primecap Management CO Pasadena, CA51.2MShares$569 Million0.49% of portfolio
-
Vanguard Group Inc Valley Forge, PA48.8MShares$543 Million0.01% of portfolio
-
Black Rock Inc. New York, NY23.3MShares$259 Million0.01% of portfolio
-
Black Creek Investment Management Inc. Toronto, A620.4MShares$227 Million11.79% of portfolio
About Elanco Animal Health Inc
- Ticker ELAN
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 474,113,984
- Market Cap $5.28B
- Description
- Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet...